Michael Buchert

12PUBLICATIONS
42CO-AUTHORS
Predictive and prognostic markersMolecular medicineConcurrency theoryInnate immunityMolecular targets
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (12)

|May 07, 2026
Circulating inflammatory ILC2s as a biomarker of gastric cancer progression.

|Jul 07, 2025
Inhibition of the minor spliceosome restricts the growth of a broad spectrum of cancers.

Karen Doggett, Kimberly J Morgan, Anouk M Olthof

|Sep 17, 2024
DCLK1 induces a pro-tumorigenic phenotype to drive gastric cancer progression.

Shoukat Afshar-Sterle, Annalisa L E Carli, Ryan O'Keefe

|Apr 12, 2024
Machine learning for medical imaging-based COVID-19 detection and diagnosis.

Rokaya Rehouma, Michael Buchert, Yi-Ping Phoebe Chen

|Feb 20, 2024
BECLIN1 is essential for intestinal homeostasis involving autophagy-independent mechanisms through its function in endocytic trafficking.

Sharon Tran, Juliani Juliani, Tiffany J Harris

|Nov 13, 2023
Mechanisms of cellular crosstalk in the gastric tumor microenvironment are mediated by YAP1 and STAT3.

Pathum Thilakasiri, Ryan N O'Keefe, Sarah Q To

Pageof 2

Frequent Collaborators

6 joint publications

Matthias Ernst

5 joint publications

Annalisa L E Carli

5 joint publications

Ryan O'Keefe

3 joint publications

Moritz F Eissmann